Cite
HARVARD Citation
Olivier, C. et al. (2018). Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome. Expert opinion on drug safety. 17 (3), pp. 251-258. [Online].